lenalidomide has been researched along with Pemphigus Foliaceus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simon, JC; Treudler, R; Vucinic, V; Zader, J | 1 |
| Adam, Z; Feit, J; Hájek, R; Klincová, M; Krejčí, M; Mayer, J; Pour, L; Szturz, P; Vašků, V; Zahradová, L | 1 |
2 other study(ies) available for lenalidomide and Pemphigus Foliaceus
| Article | Year |
|---|---|
Recalcitrant pemphigus successfully treated with lenalidomide.
Topics: Aged, 80 and over; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lenalidomide; Myelodysplastic Syndromes; Pemphigus; Remission Induction | 2020 |
Multiple myeloma associated IgA pemphigus: treatment with bortezomib- and lenalidomide-based regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Female; Humans; Immunoglobulin A; Lenalidomide; Middle Aged; Multiple Myeloma; Pemphigus; Pyrazines; Remission Induction; Thalidomide | 2011 |